Masaya Matsuzaki

Title: Masaya Matsuzaki: Innovator in APP Cleavage Activity Control

Introduction

Masaya Matsuzaki is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of Alzheimer's disease research. His innovative work focuses on methods for screening substances that control APP cleavage activity.

Latest Patents

Matsuzaki holds a patent for a "Screening method for APP cleavage activity-controlling substances of ADAMTS4." This invention provides a method for screening a substance that controls APP669 N-terminal cleavage activity. The method involves causing a candidate substance to act on a cultured cell, measuring an Aβ-related peptide produced from the cultured cell, and evaluating APP669 N-terminal cleavage activity. The candidate substances can include low molecular weight compounds, peptides, proteins, and nucleic acids. Additionally, the invention provides an APP669 N-terminal cleavage enzyme containing ADAMTS4. He has 1 patent to his name.

Career Highlights

Throughout his career, Matsuzaki has worked with prominent organizations, including Shimadzu Corporation and The University of Tokyo. His experience in these institutions has allowed him to collaborate with leading experts in his field and contribute to groundbreaking research.

Collaborations

One of his notable collaborators is Naoki Kaneko. Their partnership has likely fostered innovative ideas and advancements in their shared research interests.

Conclusion

Masaya Matsuzaki is a distinguished inventor whose work in screening methods for APP cleavage activity has the potential to impact Alzheimer's disease research significantly. His contributions to the field are noteworthy and reflect his dedication to advancing scientific knowledge.